Longpre Lara

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$10,267.60
Insider Sells Quantity
5
Insider Sells Sum
$134,195.51

Insider Activity of Longpre Lara

According to the SEC Form 4 filings, Longpre Lara, being in a position of

  1. CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1866 shares for $50,752,
    over all time since 2019-09-10, has bought 965 shares for $10,268, and sold 5795 shares for $134,196.

The largest purchase of all time was on 2019-09-10 and amounted to 965 shares of Mirum Pharmaceuticals, Inc. for $10,268.

The largest sale of all time was on 2021-10-01 and amounted to 1922 shares of Mirum Pharmaceuticals, Inc. for $37,010.

Biography of Longpre Lara

No biography is available at this moment.

2024-02-02SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF DEVELOPMENT OFFICER
847
0.0018%
$26.19$22,184+7.2%
2024-01-08SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF DEVELOPMENT OFFICER
1,019
0.0022%
$28.04$28,568-1.79%
2023-07-03SaleMirum Pharmaceuticals, Inc.
MIRM
Chief Development Officer
1,004
0.0027%
$25.65$25,749+5.32%
2023-01-09SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF DEVELOPMENT OFFICER
1,003
0.0027%
$20.62$20,684
2021-10-01SaleMirum Pharmaceuticals, Inc.
MIRM
Chief Development Officer
1,922
0.0063%
$19.26$37,010+13.33%
2019-09-10PurchaseMirum Pharmaceuticals, Inc.
MIRM
CHIEF DEVELOPMENT OFFICER
965
0.0056%
$10.64$10,268
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.